Okano K, Wu S, Huang X, Pirola C J, Juppner H, Abou-Samra A B, Segre G V, Iwasaki K, Fagin J A, Clemens T L
Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048.
Endocrinology. 1994 Sep;135(3):1093-9. doi: 10.1210/endo.135.3.8070351.
PTH-related protein (PTHrP) is produced in vascular smooth muscle, where it is believed to act as a local vasorelaxant by activating either the classical PTH or a unique PTHrP receptor. We used a newly cloned complementary DNA encoding the rat PTH/PTHrP receptor to study the expression of its messenger RNA (mRNA) in primary aortic vascular smooth muscle cells (VSMC) and in UMR-106 osteoblast-like cells under basal conditions and in response to treatment with agonists. Both cell types expressed a 2.4-kilobase PTH/PTHrP receptor mRNA transcript and exhibited hormone-induced desensitization of PTHrP-(1-34)NH2-stimulated cAMP. In VSMC, angiotensin-II, which induces PTHrP expression, also rapidly (30 min) desensitized the cAMP response and down-regulated (75-90%) receptor mRNA within 1 h. Treatment of cells with phorbol 12-myristate 13-acetate (0.1 microM) mimicked these effects, whereas neither PTHrP-(1-34)NH2, forskolin, nor (Bu)2cAMP altered receptor mRNA expression. By contrast, in UMR-106 cells, PTHrP-(1-34)NH2 induced time- and dose-dependent decreases in receptor mRNA that were preceded by pronounced desensitization (cAMP and ligand binding) of cell surface receptors. These effects were mimicked by (Bu)2cAMP and forskolin, but not by phorbol 12-myristate 13-acetate, suggesting that both receptor mRNA down-regulation and receptor desensitization in UMR cells were mediated through a protein kinase-A pathway. We suggest that VSMC and UMR cells express a common receptor, which is subject to cell-specific regulation. Such diversity in the PTH/PTHrP receptor regulatory mechanisms provides a means for restricting the length and duration of the cellular response to hormone in a cell/tissue-specific manner.
甲状旁腺激素相关蛋白(PTHrP)在血管平滑肌中产生,据信它通过激活经典的甲状旁腺激素(PTH)受体或独特的PTHrP受体而作为一种局部血管舒张剂发挥作用。我们使用新克隆的编码大鼠PTH/PTHrP受体的互补DNA,研究其信使核糖核酸(mRNA)在原代主动脉血管平滑肌细胞(VSMC)和UMR-106成骨样细胞在基础条件下以及对激动剂处理的反应中的表达。两种细胞类型均表达2.4千碱基的PTH/PTHrP受体mRNA转录本,并表现出激素诱导的对PTHrP-(1-34)NH2刺激的环磷酸腺苷(cAMP)的脱敏作用。在VSMC中,诱导PTHrP表达的血管紧张素-II也迅速(30分钟)使cAMP反应脱敏,并在1小时内下调(75 - 90%)受体mRNA。用佛波醇12-肉豆蔻酸酯13-乙酸酯(0.1 microM)处理细胞可模拟这些作用,而PTHrP-(1-34)NH2、福斯可林或双丁酰环磷腺苷((Bu)2cAMP)均未改变受体mRNA表达。相比之下,在UMR-106细胞中,PTHrP-(1-34)NH2诱导受体mRNA呈时间和剂量依赖性下降,在此之前细胞表面受体出现明显的脱敏(cAMP和配体结合)。这些作用被(Bu)2cAMP和福斯可林模拟,但未被佛波醇12-肉豆蔻酸酯13-乙酸酯模拟,这表明UMR细胞中受体mRNA下调和受体脱敏均通过蛋白激酶-A途径介导。我们认为VSMC和UMR细胞表达一种共同的受体,该受体受到细胞特异性调节。PTH/PTHrP受体调节机制中的这种多样性提供了一种以细胞/组织特异性方式限制细胞对激素反应的长度和持续时间的手段。